CAS RN: 3080-99-7
3,4-Dihydro-2H-benzo[b][1,4]thiazine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251007
250mg / 1g / 5g / 10g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g, 10g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 3080-99-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥97%
0
Out of Stock
Hong Kong
Inquiry
10g
≥97%
0
Out of Stock
Shanghai
Inquiry
3080-99-7 / 3,4-dihydro-2H-1,4-benzothiazine
Standard CAS: 3080-99-7
Multi CAS: Yes
Basic Information
copy
CAS
3080-99-7 copy
Multi CAS
Yes copy
Molecular Formula
C8H9NS copy
Molecular Weight
151.230000 copy
Exact Mass
151.045570 copy
InChI
InChI=1S/C8H9NS/c1-2-4-8-7(3-1)9-5-6-10-8/h1-4,9H,5-6H2 copy
InChIKey
YBBLSBDJIKMXNQ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.25 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
45.66 copy
TPSA
12.03 copy
LogP / Solubility
WLOGP
2.2 copy
MLOGP
1.93 copy
XLogP3
2.2 copy
Consensus LogP
2.11 copy
Log S (ESOL)
-2.61 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.39 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.47 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.08 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy